Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $6.32 and traded as high as $8.3450. Nxera Pharma shares last traded at $8.3450, with a volume of 300 shares traded.
Nxera Pharma Stock Performance
The company has a fifty day moving average of $6.41 and a 200-day moving average of $6.28.
About Nxera Pharma
Nxera Pharma Co, Ltd., formerly known as Sosei Group Corporation, is a biopharmaceutical company focused on the discovery and development of medicines targeting G protein-coupled receptors (GPCRs). The company combines structure-based drug design, computational technologies and translational research to identify potential treatments for diseases with significant unmet medical needs.
Nxera’s activities include proprietary drug discovery, preclinical and clinical development, and collaborations with pharmaceutical and biotechnology companies.
Further Reading
- Five stocks we like better than Nxera Pharma
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
